Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1) *

BIOCERES CROP SOLUTIONS CORP.

ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE

(Title of Class of Securities)

G1117K114

(CUSIP Number)

December 31, 2023

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☒

Rule 13d-1(b)

☐

Rule 13d-1(c)

☐

Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Continued on following pages

Page 1 of 5 Pages

CUSIP No. G1117K114

Page 2 of 5 Pages

1	NAMES OF REPORTING PERSONS
	SOLEL PARTNERS, LP

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☐
3	SEC USE ONLY


4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			4,579,364

		6	SHARED VOTING POWER
			0

		7	SOLE DISPOSITIVE POWER
			4,579,364

		8	SHARED DISPOSITIVE POWER
			0

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	4,579,364

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	7.3%

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	IA

Page 3 of 5 Pages

Item 1(a).

Name of Issuer:

Bioceres Crop Solutions Corp.

Item 1(b).

Address of Issuer’s Principal Executive Offices:

Ocampo 210 bis, Predio CCT, Rosario

Province of Santa Fe, Argentina

Item 2(a).

Name of Person Filing

Solel Partners LP (the “Reporting Person”)

Item 2(b).

Address of Principal Business Office or, if None, Residence:

Solel Partners LP

699 Boylston Street, 15^th Floor

Boston, MA 02116

Item 2(c).

Citizenship:

United States - Delaware

Item 2(d).

Title of Class of Securities:

Ordinary shares, par value $0.0001 per share (the “Shares”)

Item 2(e).

CUSIP Number:

G1117K114

Item 3.

If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

(e)

☒

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

Item 4.

Ownership:

Item 4(a).

Amount Beneficially Owned: 4,579,364

Item 4(b).

Percent of Class: 7.3%

Item 4(c).

Number of Shares as to which such person has:

(i) Sole power to vote or direct the vote: 4,579,364

(ii) Shared power to vote or direct the vote: 0

(iii) Sole power to dispose or direct the disposition of: 4,579,364

(iv) Shared power to dispose or direct the disposition of: 0

Page 4 of 5 Pages

Item 5.

Ownership of Five Percent or Less of a Class:

This Item 5 is not applicable.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person:

Solel-Bioceres SPV, L.P. is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares covered by this Statement that may be deemed to be beneficially owned by the Reporting Person.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

This Item 7 is not applicable.

Item 8.

Identification and Classification of Members of the Group:

This Item 8 is not applicable.

Item 9.

Notice of Dissolution of Group:

This Item 9 is not applicable.

Item 10.

Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Page 5 of 5 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.